UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Powers Advisory Group LLC

Powers Advisory Group LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 418 shares of the healthcare conglomerate’s stock after acquiring an additional 19 shares during the period. Powers Advisory Group LLC’s holdings in UnitedHealth Group were worth $244,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Resonant Capital Advisors LLC lifted its position in UnitedHealth Group by 16.2% during the third quarter. Resonant Capital Advisors LLC now owns 2,587 shares of the healthcare conglomerate’s stock valued at $1,513,000 after purchasing an additional 361 shares during the period. Veracity Capital LLC boosted its stake in shares of UnitedHealth Group by 5.7% in the third quarter. Veracity Capital LLC now owns 1,170 shares of the healthcare conglomerate’s stock worth $684,000 after buying an additional 63 shares during the last quarter. Wealth Alliance Advisory Group LLC raised its position in UnitedHealth Group by 2.8% during the third quarter. Wealth Alliance Advisory Group LLC now owns 4,700 shares of the healthcare conglomerate’s stock valued at $2,748,000 after acquiring an additional 128 shares in the last quarter. Waypoint Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Waypoint Capital Advisors LLC now owns 5,181 shares of the healthcare conglomerate’s stock worth $3,029,000 after purchasing an additional 78 shares during the period. Finally, WestHill Financial Advisors Inc. lifted its stake in shares of UnitedHealth Group by 11.8% in the 3rd quarter. WestHill Financial Advisors Inc. now owns 485 shares of the healthcare conglomerate’s stock valued at $284,000 after purchasing an additional 51 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $569.61 on Friday. The firm has a market cap of $524.26 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 1.69 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock’s 50-day moving average price is $584.42 and its 200 day moving average price is $534.15. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm earned $6.56 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on UNH shares. Robert W. Baird upped their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Finally, Stephens cut their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $615.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.